Please login to the form below

Not currently logged in


This page shows the latest market news and features for those working in and with pharma, biotech and healthcare.

bluebird bio anticipates lift of clinical holds on LentiGlobin in mid-2021

bluebird bio anticipates lift of clinical holds on LentiGlobin in mid-2021

In relation to  its beta-thalassaemia gene therapy Zynteglo, bluebird bio said this would be withdrawn from the German market after unsuccessful negotiations with health authorities in that country. ... Europe. The company said that this will enable

Latest news

More from news
Approximately 161 fully matching, plus 4,809 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 91 fully matching, plus 663 partially matching documents found.

Latest appointments

More from appointments
Approximately 9 fully matching, plus 420 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 258 fully matching, plus 1,263 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...